Your browser doesn't support javascript.
loading
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).
Leone, Francesco; Marino, Donatella; Cereda, Stefano; Filippi, Roberto; Belli, Carmen; Spadi, Rosella; Nasti, Guglielmo; Montano, Massimo; Amatu, Alessio; Aprile, Giuseppe; Cagnazzo, Celeste; Fasola, Gianpiero; Siena, Salvatore; Ciuffreda, Libero; Reni, Michele; Aglietta, Massimo.
Afiliación
  • Leone F; Department of Oncology, University of Turin Medical School/Piedmont Foundation for Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy.
  • Marino D; Department of Oncology, University of Turin Medical School/Piedmont Foundation for Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy.
  • Cereda S; Department of Medical Oncology, San Raffaele Scientific Institute, IRCCS, Milan, Italy.
  • Filippi R; Department of Oncology, University of Turin Medical School/Piedmont Foundation for Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy.
  • Belli C; Department of Medical Oncology, San Raffaele Scientific Institute, IRCCS, Milan, Italy.
  • Spadi R; Department of Oncology, Medical Oncology 1 Division, Città Della Salute e Della Scienza Hospital and University, Turin, Italy.
  • Nasti G; Department of Colorectal Oncology, National Cancer Institute G. Pascale Foundation, Naples, Italy.
  • Montano M; Department of Colorectal Oncology, National Cancer Institute G. Pascale Foundation, Naples, Italy.
  • Amatu A; Niguarda Cancer Center, Niguarda Ca' Granda Hospita, Milan, Italy.
  • Aprile G; Department of Oncology, University and General Hospital, Udine, Italy.
  • Cagnazzo C; Department of Oncology, University of Turin Medical School/Piedmont Foundation for Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy.
  • Fasola G; Department of Oncology, University and General Hospital, Udine, Italy.
  • Siena S; Niguarda Cancer Center, Niguarda Ca' Granda Hospita, Milan, Italy.
  • Ciuffreda L; Department of Oncology, Medical Oncology 1 Division, Città Della Salute e Della Scienza Hospital and University, Turin, Italy.
  • Reni M; Department of Medical Oncology, San Raffaele Scientific Institute, IRCCS, Milan, Italy.
  • Aglietta M; Department of Oncology, University of Turin Medical School/Piedmont Foundation for Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy.
Cancer ; 122(4): 574-81, 2016 Feb 15.
Article en En | MEDLINE | ID: mdl-26540314
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Conductos Biliares Intrahepáticos / Protocolos de Quimioterapia Combinada Antineoplásica / Colangiocarcinoma / Conductos Biliares Extrahepáticos / Receptores ErbB / Neoplasias de la Vesícula Biliar Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2016 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Conductos Biliares Intrahepáticos / Protocolos de Quimioterapia Combinada Antineoplásica / Colangiocarcinoma / Conductos Biliares Extrahepáticos / Receptores ErbB / Neoplasias de la Vesícula Biliar Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2016 Tipo del documento: Article País de afiliación: Italia